212 related articles for article (PubMed ID: 35606777)
1. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
2. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
3. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
[TBL] [Abstract][Full Text] [Related]
5. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
Lin T; Jiang T; Huang X; Xu P; Liang R; Song Q; Tu X; Zhao Y; Huang L; Yue J; Wu C
Age Ageing; 2024 Jan; 53(1):. PubMed ID: 38251741
[TBL] [Abstract][Full Text] [Related]
7. Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.
Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Int J Chron Obstruct Pulmon Dis; 2021; 16():3513-3524. PubMed ID: 34992359
[TBL] [Abstract][Full Text] [Related]
8. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
Front Nutr; 2022; 9():963265. PubMed ID: 36118766
[TBL] [Abstract][Full Text] [Related]
9. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study.
Tu X; Lin T; Huang L; Tang T; Xie D; Gao L; Jiang T; Yue J
Eur Geriatr Med; 2024 Apr; 15(2):579-588. PubMed ID: 38393457
[TBL] [Abstract][Full Text] [Related]
11. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
[TBL] [Abstract][Full Text] [Related]
12. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
[TBL] [Abstract][Full Text] [Related]
13. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
14. Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Mori Y; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
Chron Respir Dis; 2022; 19():14799731221117298. PubMed ID: 35930440
[TBL] [Abstract][Full Text] [Related]
15. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.
Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K
Int J Clin Oncol; 2024 Apr; ():. PubMed ID: 38683456
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum creatinine to cystatin C ratio is associated with low tongue pressure.
Komorita Y; Ide H; Yoshinari M; Ohta Y; Nakamichi I; Fujisawa R; Fujii W; Fukuhara M
Geriatr Gerontol Int; 2024 Jan; 24(1):102-108. PubMed ID: 38110724
[TBL] [Abstract][Full Text] [Related]
17. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.
Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y
Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717
[TBL] [Abstract][Full Text] [Related]
18. Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease.
Lin YL; Chang IC; Liou HH; Wang CH; Lai YH; Kuo CH; Hsu BG
Sci Rep; 2021 Aug; 11(1):16863. PubMed ID: 34413438
[TBL] [Abstract][Full Text] [Related]
19. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
20. The serum creatinine to cystatin C ratio predicts bone fracture in patients with type 2 diabetes: The Fukuoka Diabetes Registry.
Komorita Y; Iwase M; Fujii H; Ide H; Ohkuma T; Jodai-Kitamura T; Sumi A; Yoshinari M; Nakamura U; Kitazono T
Diabetes Res Clin Pract; 2018 Dec; 146():202-210. PubMed ID: 30391334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
